Mark Bouck News Today

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

/PRNewswire/ -- Waud Capital Partners (Waud Capital), a leading growth-oriented, middle-market private equity firm, announced today that it has formed an...

/PRNewswire/ -- Waud Capital Partners (Waud Capital), a leading growth-oriented, middle-market private equity firm, announced today that it has formed an...

Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.

MORRISVILLE - TrialCard Incorporated, a Morrisville-based company, has new leadership. Mark Bouck resigned as president and CEO, the company said in a statement

/PRNewswire/ -- TrialCard Incorporated ("TrialCard" or the "Company"), a full-service life sciences commercialization partner, announced today that Scott...

MORRISVILLE, N.C., Oct. 5, 2021 /PRNewswire/ -- TrialCard Incorporated ("TrialCard" or the "Company"), a full-service life sciences commercialization partner, announced today that Scott Dulitz has been promoted to President &

MORRISVILLE, N.C., May 18, 2021 /PRNewswire/ -- Biopharmaceutical solutions provider TrialCard Incorporated is pleased to announce that Sini Abraham, Senior Vice President, Market Access Operations, has been recognized by the Triangle Business Journal with its 40 Under 40 Leadership Award.  Abraham was honored for her outstanding achievements and contributions to TrialCard and her community. Abraham joined TrialCard in June 2016 as a Program Director in Hub Services and quickly worked her w...

TrialCards Inspiring Hope Campaign Exceeds Fundraising Goal Morrisville-based companys efforts total $108,000 for the Ronald McDonald House of Durham and Wake. News provided by Share this article Share this article MORRISVILLE, N.C., April 29, 2021 /PRNewswire/ -- Biopharmaceutical solutions provider TrialCard Incorporated today announced it has surpassed its anticipated fundraising goal for Ronald McDonald House of Durham and Wake (RMH), an ambitious task made even more difficult by the COVID-...

Share this article Share this article MORRISVILLE, N.C., Jan. 14, 2021 /PRNewswire/ -- TrialCard Incorporated announced today it again achieved double-digit year-over-year revenue growth in 2020, despite the challenges presented by the COVID-19 pandemic. This growth comes after the biopharmaceutical solutions provider posted consecutive years of 44% YOY organic growth in both 2018 and 2019. "2020 was a difficult year for everyone on many different levels," said TrialCard President and CEO Mark ...